Patents by Inventor Jacob Baum

Jacob Baum has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PARASITE PURIFICATION
    Publication number: 20220204916
    Abstract: The invention relates to parasites, and to methods for purifying a metabolically active obligate parasite of vertebrates and arthropods. The invention is especially concerned with methods of purifying Plasmodium and Theileria parasites, such as P. falciparum and T. parva, and highly motile parasite forms thereof, called sporozoites. The invention also relates to obligate parasites of vertebrates and arthropods purified by the methods of the invention and their use thereof.
    Type: Application
    Filed: May 6, 2020
    Publication date: June 30, 2022
    Applicant: Imperial College Innovations Limited
    Inventors: Andrew Blagborough, Joshua Blight, Arturo Reyes-Sandoval, Katarzyna Sala, Jacob Baum
  • Methods and compositions for treating and preventing malaria using an invasion ligand directed to a protease-resistant receptor
    Patent number: 9134311
    Abstract: This invention relates to an immunogenic molecule comprising a contiguous amino acid sequence of an invasion ligand of a strain of Plasmodium falciparum, the invasion ligand capable of binding to an erythrocyte receptor, the receptor function being resistant to trypsin and neuraminidase and chymotrypsin, wherein when administered to a subject the molecule is capable of inducing an immune response to the strain. The invention further relates to compositions and methods for the treatment of diseases such as malaria.
    Type: Grant
    Filed: August 27, 2009
    Date of Patent: September 15, 2015
    Assignee: Walter and Eliza Hall Institute of Medical Research
    Inventors: Alan Cowman, Lin Chen, Jacob Baum
  • METHODS AND COMPOSITIONS FOR TREATING AND PREVENTING MALARIA USING AN INVASION LIGAND DIRECTED TO A PROTEASE-RESISTANT RECEPTOR
    Publication number: 20110311571
    Abstract: This invention relates to an immunogenic molecule comprising a contiguous amino acid sequence of an invasion ligand of a strain of Plasmodium falciparum, the invasion ligand capable of binding to an erythrocyte receptor, the receptor function being resistant to trypsin and neuraminidase and chymotrypsin, wherein when administered to a subject the molecule is capable of inducing an immune response to the strain. The invention further relates to compositions and methods for the treatment of diseases such as malaria.
    Type: Application
    Filed: August 27, 2009
    Publication date: December 22, 2011
    Inventors: Alan Cowman, Lin Chen, Jacob Baum